| 1 |
35399851 | Clinical Study of Clopidogrel Combined with Huoxue Tongluo Prescription in Improving Transient Ischemic Attack and the Effect on MMP-9, Hcy, and CRP. | 2022 |
3 |
| 2 |
34671655 | Similar Inflammatory Biomarkers Reflect Different Platelet Reactivity in Percutaneous Coronary Intervention Patients Treated With Clopidogrel: A Large-Sample Study From China. | 2021 |
3 |
| 3 |
29330312 | High-sensitive C-reactive protein and dual antiplatelet in intracranial arterial stenosis. | 2018 Feb 6 |
1 |
| 4 |
26889454 | Changes of High Sensitivity C-Reactive Protein During Clopidogrel Therapy in Patients Undergoing Percutaneous Coronary Intervention. | 2016 Feb |
2 |
| 5 |
27328699 | High-Sensitive C-Reactive Protein Predicts Recurrent Stroke and Poor Functional Outcome: Subanalysis of the Clopidogrel in High-Risk Patients With Acute Nondisabling Cerebrovascular Events Trial. | 2016 Aug |
1 |
| 6 |
27597810 | Prasugrel Results in Higher Decrease in High-Sensitivity C-Reactive Protein Level in Patients Undergoing Percutaneous Coronary Intervention Comparing to Clopidogrel. | 2016 |
3 |
| 7 |
26771969 | Prolonged CRP Increase After Percutaneous Coronary Intervention Is Associated with High Thrombin Concentrations and Low Platelet' Response to Clopidogrel in Patients with Stable Angina. | 2015 Nov-Dec |
2 |
| 8 |
21602258 | Relationship between plasma inflammatory markers and platelet aggregation in patients with clopidogrel resistance after angioplasty. | 2012 Jan |
1 |
| 9 |
24293976 | No effect of clopidogrel activity or cessation on vascular function or markers of inflammation. | 2012 Dec |
1 |
| 10 |
21310311 | High versus standard clopidogrel maintenance dose after percutaneous coronary intervention and effects on platelet inhibition, endothelial function, and inflammation results of the ARMYDA-150 mg (antiplatelet therapy for reduction of myocardial damage during angioplasty) randomized study. | 2011 Feb 15 |
1 |
| 11 |
21393433 | High-sensitivity C-reactive protein and clopidogrel treatment in patients at high risk of cardiovascular events: a substudy from the CHARISMA trial. | 2011 Apr |
1 |
| 12 |
20838744 | Association between inflammatory biomarkers and platelet aggregation in patients under chronic clopidogrel treatment. | 2010 Dec |
1 |
| 13 |
18801777 | Pre-procedural C-reactive protein levels and clinical outcomes after percutaneous coronary interventions with and without abciximab: pooled analysis of four ISAR trials. | 2009 Feb |
2 |
| 14 |
17615799 | Clinical evidence for anti-inflammatory effects of antiplatelet therapy in patients with atherothrombotic disease. | 2007 May |
1 |
| 15 |
16679086 | Comparison of effects of bare metal versus drug-eluting stent implantation on biomarker levels following percutaneous coronary intervention for non-ST-elevation acute coronary syndrome. | 2006 May 15 |
1 |
| 16 |
17161243 | Effect of clopidogrel with and without eptifibatide on tumor necrosis factor-alpha and C-reactive protein release after elective stenting: results from the CLEAR PLATELETS 1b study. | 2006 Dec 5 |
1 |
| 17 |
15276105 | Effect of clopidogrel pretreatment on periprocedural rise in C-reactive protein after percutaneous coronary intervention. | 2004 Aug 1 |
5 |
| 18 |
15550024 | A randomized comparison of the effects of aspirin and clopidogrel on thrombotic risk factors and C-reactive protein following myocardial infarction: the CADET trial. | 2004 Nov |
1 |
| 19 |
12714834 | Changes in platelet P-selectin and in plasma C-reactive protein in acute atherosclerotic ischemic stroke treated with a loading dose of clopidogrel. | 2002 Oct |
5 |